Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Calvo, Katherine R  [Clear All Filters]
2023
Wu Z, Gao S, Gao Q, Patel BA, Groarke EM, Feng X, Manley ALee, Li H, Cardona DOspina, Kajigaya S, et al. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS. Cell Rep Med. 2023;4(8):101160.
Obiorah IE, Upadhyaya KD, Calvo KR. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications. Clin Lab Med. 2023;43(4):615-638.
Patel N, Calvo KR. How I diagnose myeloid neoplasms with germline predisposition. Am J Clin Pathol. 2023.
Liu PP, Cunningham L, Merguerian MDouglas, Calvo KR, Davis J, Deuitch NT, Dulau-Florea AE, Patel N, Yu K, Sacco K, et al. Natural History Study of Patients with Familial Platelet Disorder with Myeloid Malignancy. Blood. 2023.
2022
Young DJ, Fan X, Groarke EM, Patel B, Desmond R, Winkler T, Larochelle A, Calvo KR, Young NS, Dunbar CE. Long-term eltrombopag for bone marrow failure depletes iron. Am J Hematol. 2022.
Shin T-H, Zhou Y, Chen S, Cordes S, Grice MZ, Fan X, Lee B-C, AlJanahi AA, Hong SGun, Vaughan KL, et al. Macaque Clonal Hematopoiesis Model Demonstrates Expansion of TET2-Disrupted Clones and Utility for Testing Interventions. Blood. 2022.
Lee B-C, Zhou Y, Bresciani E, Ozkaya N, Florea ADulau, Carrington B, Shin T-H, Baena V, Syed ZA, Hong SGun, et al. A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies. Blood. 2022.
Hickstein DD, Calvo KR. The Spectrum of GATA2 Deficiency Syndrome. Blood. 2022.
2020
Johnson KD, Conn DJ, Shishkova E, Katsumura KR, Liu P, Shen S, Ranheim EA, Kraus SG, Wang W, Calvo KR, et al. Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories. J Exp Med. 2020;217(11).
Fan X, Desmond R, Winkler T, Young DJ, Dumitriu B, Townsley DM, Gutierrez-Rodrigues F, Lotter J, Valdez J, Sellers SE, et al. Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Adv. 2020;4(8):1700-1710.
Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, Balanda N, Ross DL, Cardona DOspina, Wu Z, et al. Somatic Mutations in and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med. 2020.
Wilson NR, Fang H, Loghavi S, Wang W, Tang G, Haltom RO, Rausch CR, McClain KL, Rao KV, Popat UR, et al. Treating Rosai-Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. Br J Haematol. 2020.
2016
Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, Ganson NJ, Hershfield MS, Holland SM, Hickstein DD. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2016.
2014
McDermott DH, Liu Q, Velez D, Lopez L, Anaya-O'Brien S, Ulrick J, Kwatemaa N, Starling J, Fleisher TA, Priel DALong, et al. A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood. 2014.